Study Finds Most Patients Adhere to Long-Acting HIV Therapy

A large real-world study found that most people who switched from daily oral HIV therapy to long-acting injections continued with the new regimen, with few experiencing virologic failure. This finding may help reduce healthcare providers' concerns about adherence challenges with long-acting HIV treatments, according to Dr. Ricky Hsu.

Originally published by gnews